Literature DB >> 23088643

Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease brain.

Harald Lund1, Richard F Cowburn, Elin Gustafsson, Kia Strömberg, Anne Svensson, Leif Dahllund, David Malinowsky, Dan Sunnemark.   

Abstract

Recent reports have implicated tau-tubulin kinase 1 (TTBK1) in the pathological phosphorylation of tau that occurs in Alzheimer's disease (AD). The present study was undertaken to provide an extensive characterization of TTBK1 mRNA and protein expression in human brain from AD cases and non-demented controls so as to better understand the disease relevance of this novel kinase. In situ hybridization and immunohistochemistry revealed abundant expression of TTBK1 in the somatodendritic compartment of cortical and hippocampal neurons of both AD cases and controls. TTBK1 immunoreactivity appeared to vary with the level of phospho-tau staining, and was strong in the somatodendritic compartment of apparently healthy hippocampal neurons as well as in pre-tangle neurons where it co-localized with diffuse phospho-Ser422 tau staining. Ser422 was confirmed as a TTBK1 substrate in vitro, and an antibody towards the site, in addition to labeling AT8-positive neurofibrillary tangles (NFTs), neuritic plaques and neuropil threads, also labeled a small population of neurons that were unlabeled with AT8. These data suggest a role for TTBK1 in pre-tangle formation prior to the formation of fibrillar tau and strengthen the idea that tau is phosphorylated at Ser422 at an early/intermediate stage in NFT formation.
© 2012 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088643     DOI: 10.1111/bpa.12001

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  21 in total

1.  The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor.

Authors:  Susan E Kiefer; Chiehying J Chang; S Roy Kimura; Mian Gao; Dianlin Xie; Yaqun Zhang; Guifen Zhang; Martin B Gill; Harold Mastalerz; Lorin A Thompson; Angela M Cacace; Steven Sheriff
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-01-21       Impact factor: 1.056

2.  Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.

Authors:  Hirohide Asai; Seiko Ikezu; Maya E Woodbury; Grant M S Yonemoto; Libin Cui; Tsuneya Ikezu
Journal:  Am J Pathol       Date:  2014-01-10       Impact factor: 4.307

3.  Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks.

Authors:  Hans-Ulrich Klein; Martin Schäfer; David A Bennett; Holger Schwender; Philip L De Jager
Journal:  PLoS Comput Biol       Date:  2020-04-07       Impact factor: 4.475

Review 4.  Tau tubulin kinases in proteinopathy.

Authors:  Laura M Taylor; Pamela J McMillan; Brian C Kraemer; Nicole F Liachko
Journal:  FEBS J       Date:  2019-05-22       Impact factor: 5.542

Review 5.  TTBK2: a tau protein kinase beyond tau phosphorylation.

Authors:  Jung-Chi Liao; T Tony Yang; Rueyhung Roc Weng; Ching-Te Kuo; Chih-Wei Chang
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

6.  The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43.

Authors:  Nicole F Liachko; Pamela J McMillan; Timothy J Strovas; Elaine Loomis; Lynne Greenup; Jill R Murrell; Bernardino Ghetti; Murray A Raskind; Thomas J Montine; Thomas D Bird; James B Leverenz; Brian C Kraemer
Journal:  PLoS Genet       Date:  2014-12-04       Impact factor: 5.917

7.  MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.

Authors:  Harald Lund; Elin Gustafsson; Anne Svensson; Maria Nilsson; Margareta Berg; Dan Sunnemark; Gabriel von Euler
Journal:  Acta Neuropathol Commun       Date:  2014-02-17       Impact factor: 7.801

Review 8.  Tau-tubulin kinase.

Authors:  Seiko Ikezu; Tsuneya Ikezu
Journal:  Front Mol Neurosci       Date:  2014-04-28       Impact factor: 5.639

9.  A Forward Genetic Screen for Molecules Involved in Pheromone-Induced Dauer Formation in Caenorhabditis elegans.

Authors:  Scott J Neal; JiSoo Park; Danielle DiTirro; Jason Yoon; Mayumi Shibuya; Woochan Choi; Frank C Schroeder; Rebecca A Butcher; Kyuhyung Kim; Piali Sengupta
Journal:  G3 (Bethesda)       Date:  2016-05-03       Impact factor: 3.154

10.  De novo variants in sporadic cases of childhood onset schizophrenia.

Authors:  Amirthagowri Ambalavanan; Simon L Girard; Kwangmi Ahn; Sirui Zhou; Alexandre Dionne-Laporte; Dan Spiegelman; Cynthia V Bourassa; Julie Gauthier; Fadi F Hamdan; Lan Xiong; Patrick A Dion; Ridha Joober; Judith Rapoport; Guy A Rouleau
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.